Portfolia Rising America Fund (RAF)

www.portfolia.co

VCMatch tracks Portfolia Rising America Fund (RAF) as an investor focused on AI/ML, Healthtech, and Digital Health companies, Series C rounds, and United States and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Series C

Focus Areas

AI/ML, Healthtech, Digital Health

Geography

United States and Global

Investment Thesis

Portfolia’s investment philosophy centers on building purpose-built, thematic venture funds led by and for women (but open to all) that target undercapitalized, high-burden areas of women’s health. They prioritize science-driven, data-rich, infrastructure-level platforms that can deliver measurable clinical outcomes and strong financial returns — combining domain expertise, clinical validation, and an engaged investor community to source, diligence, and scale category-defining companies.

Is Portfolia Rising America Fund (RAF) right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Portfolia Rising America Fund (RAF) is most relevant for founders raising Series C rounds in AI/ML, Healthtech, Digital Health, and Biotech, especially across United States and Global.

Focus statement

Portfolia focuses on women's health across the full female healthspan (fertility/IVF, maternal health, menopause, autoimmune, cardiovascular, oncology, diagnostics, and enabling data/AI infrastructure) and on AI-driven, outcomes-focused companies that address conditions that are specific to, different for, or disproportionately affect women.

Value Add

Purpose-built funds "designed by and for women, open to all" rather than a small women's-health sleeve inside a generalist fund.
Largest/most active footprint in category metrics cited on the site: "46+ portfolio companies" and "100+ investments" with a "2,000+" member community (enables pattern recognition and dealflow).
Community-driven model: a network of >2,000 members who contribute lived experience, clinical perspective and distribution support to portfolio companies.
Thesis-driven, thematic funds (Women’s Health Fund IV highlighted) that combine domain expertise, clinical validation, and data moats rather than consumer marketing-led plays.
Emphasis on infrastructure and integration: backing diagnostic, data, and interoperability platforms (e.g., Mirvie, b.well) that embed into clinical workflows and payer/provider channels.
Outcomes and validation focus: prioritizes companies that demonstrate measurable improvements (reduced time to diagnosis, improved treatment outcomes, payer value) rather than engagement metrics alone.